ASGCT News

Filter By

Recent Articles

ASGCT Gears Up for 2021 Policy Progress

Francesca Cook, MPH | January 12, 2021

Read about the Society's policy and advocacy successes of 2020 and our goals for 2021.

Policy Updates
Read Full Story

Learn How mRNA Vaccines Offer Protection from COVID-19

ASGCT Staff | December 30, 2020

ASGCT has created new Patient Education resources to explain how the new mRNA vaccines work to offer protection from COVID-19.

Education
Read Full Story

2020 Gene Therapy Progress Wrap-Up

Edith Pfister, Ph.D. | December 22, 2020

Dr. Pfister summarizes some of the year's most notable gene and cell therapy developments.

Read Full Story

Two Vaccines in One Week Set Foundation for mRNA Platform Technology

Cenk Sumen, Ph.D. | December 21, 2020

The variations between the two vaccines are minimal and mainly reflect the doses and different lipid nanoparticles used in their formulations, Dr. Sumen explains.

Read Full Story

Second mRNA Vaccine for COVID-19 Approved in the U.S.

Stephen J. Russell, M.D., Ph.D. | December 18, 2020

ASGCT President Stephen J. Russell, M.D., Ph.D. reacts to today's FDA approval of the second COVID-19 vaccine authorized for use in the U.S.

ASGCT News   |   President's Message
Read Full Story

Understanding Ethical Concerns About Germline Gene Editing

ASGCT Staff | December 16, 2020

Our newest Patient Education resource on germline gene editing addresses key questions that patients, families, and the public may have about this technology.

Education
Read Full Story

Distribution of First Approved COVID-19 Vaccine in the U.S. Presents Challenges

Edith Pfister, Ph.D. | December 16, 2020

Edith Pfister, Ph.D., discusses several challenges following approval of the first COVID-19 vaccine in the U.S.

Read Full Story

Communicating Science: Perspectives from Molecular Therapy Executive Editor Dr. Robert Frederickson

Kenji Rowel Lim | December 14, 2020

Kenji Rowel Lim discusses the challenges of communicating science with Molecular Therapy Executive Editor Robert Frederickson, Ph.D.

Read Full Story

Approved mRNA Vaccine for COVID-19 is a Milestone for Gene and Cell Therapy

Stephen J. Russell, M.D., Ph.D. | December 11, 2020

ASGCT President Stephen J. Russell, M.D., Ph.D. reacts to today's FDA approval of the first COVID-19 vaccine authorized for use in the U.S.

ASGCT News   |   President's Message
Read Full Story

Registration is Now Open For ASGCT's Virtual 24th Annual Meeting

ASGCT Staff | December 08, 2020

We're excited to offer a more robust virtual environment for the premier event in gene and cell therapy.

Annual Meeting
Read Full Story

ASGCT Holds First Joint Meeting With Brazilian Association

ASGCT Staff | December 03, 2020

Speakers addressed the scientific and infrastructural requirements for successful translation into clinical research for oncology, hemophilia, and sickle cell disease.

ASGCT News
Read Full Story

Two mRNA COVID-19 Vaccines Advance in U.K. and U.S.

ASGCT Staff | December 03, 2020

A vaccine from Pfizer and BioNTech was approved this week for emergency use in the U.K., while the FDA will meet this month to discuss its emergency use authorization in the U.S. 

COVID Symposium
Read Full Story

ASGCT Holds Third Annual FDA Liaison Meeting

ASGCT Staff | November 24, 2020

View presentation slides from ASGCT's third annual liaison meeting with the FDA’s Center for Biologics Evaluation and Research (CBER) on November 16.

Advocacy
Read Full Story

Exploring Gene and Cell Therapies for Prostate Cancer

Eoghan J. Mulholland, Ph.D. | November 19, 2020

To recognize International Men's Day, Dr. Eoghan Mulholland describes how gene and cell therapies could eventually lead to the treatment and prevention of prostate cancer.

ASGCT News
Read Full Story

COVID-19 Vaccine Candidates Show Gene Therapy is a Viable Strategy

ASGCT Staff | November 17, 2020

Findings from Moderna and Pfizer demonstrate that gene therapy is a viable strategy for developing vaccines to combat COVID-19.

COVID Symposium
Read Full Story

Submit Your Abstracts for the 24th Annual Meeting

ASGCT Staff | November 16, 2020

The #ASGCT21 Call for Abstracts is now open through January 27, 2021.

Annual Meeting
Read Full Story
2021

ASGCT 24th Annual Meeting

May 11-14, 2021